Browse
Submit Data
Databases
API
Help

Dataset Information

16 Views

0 Connections

0 Citations

0 Reanalyses

0 Downloads

Omics score: 0

Guiding dengue vaccine development using knowledge gained from the success of the yellow fever vaccine.

ABSTRACT: Flaviviruses comprise approximately 70 closely related RNA viruses. These include several mosquito-borne pathogens, such as yellow fever virus (YFV), dengue virus (DENV), and Japanese encephalitis virus (JEV), which can cause significant human diseases and thus are of great medical importance. Vaccines against both YFV and JEV have been used successfully in humans for decades; however, the development of a DENV vaccine has encountered considerable obstacles. Here, we review the protective immune responses elicited by the vaccine against YFV to provide some insights into the development of a protective DENV vaccine.

SUBMITTER: Liang H

PROVIDER: S-EPMC4711684 | biostudies-other | 2016 Jan

REPOSITORIES: biostudies-other

ACCESS DATA

Json Xml

Similar Datasets

A DNA vaccine against yellow fever virus: development and evaluation.

Project description: Not available

| S-EPMC4395287 | biostudies-literature

Immune response to the yellow fever vaccine 17D.

Project description:Correlates of immune mediated protection to most viral and cancer vaccines are still unknown. This impedes the development of novel vaccines to incurable diseases such as HIV and cancer. In this study, we have used functional genomics and polychromatic flow cytometry to define the signature of the immune response to the yellow fever (YF) vaccine 17D (YF17D) in a cohort of forty volunteers followed for up to one year after vaccination. We show that immunization with YF17D leads to an integrated immune response that includes several effector arms of innate immunity including complement, the inflammasome and interferons, as well as adaptive immunity as shown by an early T cell response followed by a brisk and variable B cell response. Development of these responses is preceded, as demonstrated in three independent vaccination trials and in a novel in vitro system of primary immune responses (Modular IMmune In vitro Construct (MIMIC) system), by the coordinated up-regulation of transcripts for specific transcription factors including STAT1, IRF7 and ETS2 that are upstream of the different effector arms of the immune response. These results clearly show that the immune response to a strong vaccine is preceded by coordinated induction of masters transcription factors, that lead to the development of a broad, polyfunctional and persistent immune response that integrates all effector cells of the immune system.

2008-12-01 | GSE13699 | GEO

Dengue Fever: Causes, Complications, and Vaccine Strategies.

Project description: Not available

| S-EPMC4971387 | biostudies-other

Dissecting Antibodies Induced by a Chimeric Yellow Fever-Dengue, Live-Attenuated, Tetravalent Dengue Vaccine (CYD-TDV) in Naive and Dengue-Exposed Individuals.

Project description: Not available

| S-EPMC6392503 | biostudies-literature

Construction, safety, and immunogenicity in nonhuman primates of a chimeric yellow fever-dengue virus tetravalent vaccine.

Project description: Not available

| S-EPMC114964 | biostudies-literature

Yellow fever virus/dengue-2 virus and yellow fever virus/dengue-4 virus chimeras: biological characterization, immunogenicity, and protection against dengue encephalitis in the mouse model.

Project description: Not available

| S-EPMC149507 | biostudies-literature

Expression data from Yellow Fever 17D vaccine immunized healthy subjects

Project description:To better understand how innate immunity to vaccination can lead to lasting protective immunity, we have used systemic bioinformatics approaches to define the signature of the yellow fever specific immune response in a cohort of 21 volunteers.

2017-06-25 | GSE82152 | GEO

The synergistic effect of combined immunization with a DNA vaccine and chimeric yellow fever/dengue virus leads to strong protection against dengue.

Project description: Not available

| S-EPMC3589436 | biostudies-literature

Yellow fever virus exhibits slower evolutionary dynamics than dengue virus.

Project description: Not available

| S-EPMC2798388 | biostudies-literature

Repurposing the yellow fever vaccine for intratumoral immunotherapy.

Project description: Not available

| S-EPMC6949490 | biostudies-literature